These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37033208)

  • 21. [Quality of life in patients with lower urinary tract symptoms after TURP for benign prostatic hyperplasia].
    Pushkar DY; Bernikov AN; Khodyreva LA; Dudareva AA; Al'-Shukri SK; Amdii RE; Aboyan IA; Shiranov KA; Medvedev VL; Efremov ME
    Urologiia; 2018 Mar; (1):53-61. PubMed ID: 29634135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Transurethral Resection of the Prostate on Storage Symptoms in Patients with Benign Prostatic Hyperplasia of Less than 30 ml.
    Kang YJ; Kim KH; Seo Y; Lee KS
    World J Mens Health; 2013 Apr; 31(1):64-9. PubMed ID: 23658868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of benign prostatic hyperplasia surgical treatment with turp method on the quality of life.
    Milicevic S
    Acta Inform Med; 2011 Sep; 19(3):142-5. PubMed ID: 23407383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
    Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA
    Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of key genes in benign prostatic hyperplasia using bioinformatics analysis.
    Xiang P; Liu D; Guan D; Du Z; Hao Y; Yan W; Wang M; Ping H
    World J Urol; 2021 Sep; 39(9):3509-3516. PubMed ID: 33564912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
    Jin R; Strand DW; Forbes CM; Case T; Cates JMM; Liu Q; Ramirez-Solano M; Milne GL; Sanchez S; Wang ZY; Bjorling DE; Miller NL; Matusik RJ
    Prostate; 2021 Sep; 81(13):944-955. PubMed ID: 34288015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective randomized study comparing bipolar plasmakinetic transurethral resection of the prostate and monopolar transurethral resection of the prostate for the treatment of Benign Prostatic Hyperplasia: efficacy, sexual function, Quality of Life, and complications.
    Otaola-Arca H; Álvarez-Ardura M; Molina-Escudero R; Fernández MI; Páez-Borda Á
    Int Braz J Urol; 2021; 47(1):131-144. PubMed ID: 33047918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective observation of the efficacy and safety of prostatic artery embolization combined with transurethral resection of the prostate and simple transurethral resection of the prostate in the treatment of large (> 100 mL) benign prostatic hyperplasia.
    Tang Y; Wang RL; Ruan DD; Chen X; Zhou YF; Wu SJ; Cai SL; Zhang JH; Yang FG; Luo JW; Fang ZT
    Abdom Radiol (NY); 2021 Dec; 46(12):5746-5757. PubMed ID: 34448024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does histological prostatic inflammation during transurethral resection of the prostate for bladder outlet obstruction affect post-operative urinary outcomes?
    Arora B; Khan M; Pridgeon S
    Low Urin Tract Symptoms; 2023 Mar; 15(2):57-62. PubMed ID: 36691261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-catenin is elevated in human benign prostatic hyperplasia specimens compared to histologically normal prostate tissue.
    Bauman TM; Vezina CM; Huang W; Marker PC; Peterson RE; Ricke WA
    Am J Clin Exp Urol; 2014; 2(4):313-22. PubMed ID: 25606577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of Prostate Artery Embolisation in Patients with Severe Symptoms of Benign Prostate Hyperplasia.
    Abdul Rahim R; Eng Hong G; Nik Ismail NA; Zakaria R
    Malays J Med Sci; 2021 Dec; 28(6):55-63. PubMed ID: 35002490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between histological prostatitis and benign prostatic hyperplasia: a single-center retrospective study.
    Li J; Li Y; Cao D; Huang Y; Peng L; Meng C; Wei Q
    Aging Male; 2022 Dec; 25(1):88-93. PubMed ID: 35289705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: A systematic review and meta-analysis.
    Wang XY; Chai YM; Huang WH; Zhang Y
    World J Clin Cases; 2022 Nov; 10(32):11812-11826. PubMed ID: 36405270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis.
    Yang Y; Sheng J; Hu S; Cui Y; Xiao J; Yu W; Peng J; Han W; He Q; Fan Y; Niu Y; Lin J; Tian Y; Chang C; Yeh S; Jin J
    Cell Death Dis; 2022 Jun; 13(6):533. PubMed ID: 35672281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
    Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
    J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential role of glutathione S-transferase P1 gene polymorphism and metabolic syndrome in lower urinary tract symptoms attributed to benign prostatic hyperplasia.
    Zhang W; Li Z; Liu M; Mu Y; He J; Chen P; Liu D; Chen K; Che B; Xu S; Zhang H; Tang K
    World J Urol; 2021 Dec; 39(12):4413-4419. PubMed ID: 34228163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.
    Popovics P; Awadallah WN; Kohrt SE; Case TC; Miller NL; Ricke EA; Huang W; Ramirez-Solano M; Liu Q; Vezina CM; Matusik RJ; Ricke WA; Grabowska MM
    Prostate; 2020 Jul; 80(10):731-741. PubMed ID: 32356572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of key genes and pathways in benign prostatic hyperplasia.
    Ke ZB; Cai H; Wu YP; Lin YZ; Li XD; Huang JB; Sun XL; Zheng QS; Xue XY; Wei Y; Xu N
    J Cell Physiol; 2019 Nov; 234(11):19942-19950. PubMed ID: 31187492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [LUTS in BPH patients with histological prostatitis before and after transurethral resection of the prostate].
    Huang XH; Qin B; Liang YW; Wu QG; Li CZ; Wei GS; Ji HC; Liang YB; Chen HQ; Guan T
    Zhonghua Nan Ke Xue; 2013 Jan; 19(1):35-9. PubMed ID: 23469659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.